DMACC

The Data Management, Auditing, and Coordinating Center for the Cancer Prevention Clinical Trials Network (CP‑CTNet)

Data Management
Clinical Trial Auditing
Administration and Coordination
Data Management
Clinical Trial Auditing
Administration and Coordination
Data Management
Clinical Trial Auditing
Administration and Coordination
Data Management
Clinical Trial Auditing
Administration and Coordination
Data Management
Clinical Trial Auditing
Administration and Coordination
Data Management
Clinical Trial Auditing
Administration and Coordination
Data Management
Clinical Trial Auditing
Administration and Coordination

About CP-CTNet

The Cancer Prevention Clinical Trials Network (CP-CTNet) is a major program of the National Cancer Institute (NCI) Division of Cancer Prevention (DCP). The purpose of CP-CTNet is to perform and provide clinical trial support for the efficient conduct of early-phase clinical trials, evaluate the biologic effects of preventive agents and interventions, and determine clinically relevant correlates in order to advance their development for cancer prevention.

The key components of CP-CTNet are the CP-CTNet sites and the CP-CTNet Data Management, Auditing, and Coordinating Center (DMACC). Each CP-CTNet site consists of a Lead Academic Organization (LAO) and Affiliated Organizations (AOs) that work together to perform cancer prevention clinical trials.

About DMACC

The Data Management, Auditing and Coordinating Center supports the CP-CTNet sites and coordinates trans-network activities for centralized data management and reporting, clinical trials auditing, and administrative and logistical coordination across CP-CTNet sites. In addition, the DMACC collaborates with and advises the CP-CTNet sites with respect to trial design and protocol development.

The DMACC is led by KyungMann Kim, PhD, of the University of Wisconsin (as Principal Investigator) and Sue Siminski, MS, MBA, of Frontier Science Foundation (as sub-Principal Investigator).